Human leukocyte antigen-binding vaccine(SLK Kliniken Heilbronn)

N/A

Report date: 2024/09/20 20:00:41

Base Information

Drug NameHuman leukocyte antigen-binding vaccine(SLK Kliniken Heilbronn)
Drug Alias NameHLA-binding vaccine(SLK Kliniken Heilbronn)IVAC-RCC-001
ClassificationVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSLK Kliniken Heilbronn GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSLK Kliniken Heilbronn GmbH
Active IndicationsN/A
Inactive IndicationsCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A